WebMitotherapeutix is included in 2 Expert Collections, including Cancer. C. Cancer. 4,784 items. Pharmaceutical and biotechnology companies with cancer therapy drug candidates. B. Biopharma Tech. 1,568 items. View All Expert Collections. Mitotherapeutix Patents. Mitotherapeutix has filed 2 patents. WebMitotherapeutix is a US-based pre-clinical stage pharmaceutical company that is developing drugs (siRNA) targeting metabolism to treat disease. Our initial program targets a protein …
Mitotherapeutix, LLC
WebMitotherapeutix was created to take advantage of advancements in RNA chemistry and its use in developing siRNA based drugs that can target otherwise difficult to address … Robert Hennessey. Co-Founder & Chairman of Board ... Mitotherapeutix has identified a unique target for its first program. Our first … Mitotherapeutix also has a program focused on Polycystic kidney disease (PKD). … Mitotherapeutix Awarded $2.2 Million SBIR Grant from the National Institutes of … For information contact us at [email protected]. 400 … WebMitotherapeutix is a US-based pre-clinical stage pharmaceutical company that is developing drugs (siRNA) targeting metabolism to treat disease. Our initial program targets a protein MCJ/DNAJC15, found in the mitochondria and is responsible for enhancing the production of energy. the djinn streaming ita
Mitotherapeutix Awarded $2.2 Million SBIR Grant from the …
WebFor information contact us at [email protected]. 400 Farmington Ave Farmington, CT 06032 T (203) 676-1709 WebMitotherapeutix was created to take advantage of advancements in RNA chemistry and its use in developing new drugs (siRNA) which can target “undruggable” disease targets. See all funding and science results with CipherBio PRO. Find Prospects. Identify leads, gain more opportunities, close more deals. WebDescription. Developer of molecules-based drugs designed for the treatment of cancer and degenerative liver disorders. The company's products are used for the treatment of … the djinn streaming